Tim Wade highlights the opportunity for gym operators and a free guide from Dr Lou Atkinson, PhD, MSc, BSc that details how to take advantage of this
Statistical Analysis Science and data through a recent survey in the US constantly suggests that surgery always outperforms GLP-1s, with the NIH comparison of surgical vs non-surgical revealing that patients who underwent bariatric surgery presented better weight loss progress and comorbidity resolutions
Sleep-related observations tend to be reported earliest
20, 2025 from Transportation Security Administration (TSA-a)
Additionally, while semaglutide generally has a favorable liver safety profile and has been approved (as Wegovy) for treating metabolic dysfunction-associated steatohepatitis (MASH) with moderate-to-advanced fibrosis based on phase 3 trials showing histological improvements, rare post-marketing cases of hepatotoxicity (elevated liver enzymes, jaundice) have been reported, typically resolving upon discontinuation
Though they have the same active ingredient as big pharmas branded weight loss drugs, compounded GLP-1s are not required to undergo the FDAs rigorous approval process